Personalized HLA-aware TCR measure predicts the risk of symptomatic SARS-CoV-2 infection following booster vaccination
HLA-driven heterogeneity and limitations of live T cell functional assays routinely thwart assessment of cell-mediated immunity in vaccination trials. To address this, we developed a T-cell receptor (TCR)-based measure of immunogen recognition and evaluated it in COV-BOOST, a third-dose COVID-19 vaccine trial, during the Delta and Omicron waves (2021-2022, United Kingdom). We estimated HLA-aware Spike-reactive T cell (HA-TS) breadth from participant HLA genotypes, TCRβ repertoires, and a novel SARS-CoV-2 S HLA-linked reference catalog. Higher post-boost HA-TS breadth was associated with lower symptomatic infection risk (HR 0.58, 95% CI 0.39-0.86). This association persisted after adjustment for neutralizing antibody titers and IFN-γ responses. Examination of HA-TS across prior studies showed that it reflects participant genotype, exposure intensity, and time from exposure to sampling. These findings highlight the possibility that estimates of antigen-specific T cell repertoire breadth could serve as a correlate of protection to accelerate vaccine development.
Authors
- Teresa Lambe (ORCID: https://orcid.org/0000-0001-7711-897X)
- Emily S. Ford (ORCID: https://orcid.org/0000-0001-7358-798X)
- Andrew J. Fiore-Gartland (ORCID: https://orcid.org/0000-0001-7627-2166)
- Alasdair Peter Stuart Munro (ORCID: https://orcid.org/0000-0002-4317-0742)
- Narges Ebrahimi (ORCID: https://orcid.org/0000-0002-8953-6842)
- Koshlan Mayer-Blackwell (ORCID: https://orcid.org/0000-0002-1652-4023)
- Jennifer Alderson (ORCID: https://orcid.org/0000-0002-0526-7797)
- Sagida Bibi (ORCID: https://orcid.org/0000-0002-0855-2737)
- Saul N. Faust (ORCID: https://orcid.org/0000-0003-3410-7642)
- Merryn Voysey (ORCID: https://orcid.org/0000-0001-6324-6559)
- Adam P. Dale (ORCID: https://orcid.org/0000-0001-8163-7481)
- Khiyam Hussain (ORCID: https://orcid.org/0000-0002-6705-4412)
- Xinxue Liu
Institutions
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- University of Washington (US)
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Oxford (GB)
- Fred Hutch Cancer Center (US)
- NIHR Southampton Biomedical Research Centre (GB)
- Oxford BioMedica (United Kingdom) (GB)
- University of Southampton (GB)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-12
- DOI
- https://doi.org/10.64898/2026.11.10.26367219
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- preprint